Stock NEPTUNE TECHNOLOGIES & BIORESSOURCES-ORD
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Neptune Technologies & Bioressources-Ord Toronto S.E.

Equities

CA64077P1080

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Neptune Technologies & Bioressources : to Present at Sidoti & Company Fall 2018 Conference
PR
Neptune Technologies & Bioressources : Confirms its Name Change to Wellness Solutions Inc.
PR
Neptune Technologies & Bioressources : Receives Confirmation of Readiness Letter from Health Canada
PR
Neptune Technologies & Bioressources : Announces Appointment of Hélène F. Fortin to its Board of Directors
PR
Neptune Technologies & Bioressources : Announces the Election of its Directors and Voting Results
PR
Neptune Technologies & Bioressources : Announces First Quarter Results
PR
Neptune Technologies & Bioressources : Cannabis Patent Applications
PU
Neptune Technologies & Bioressources : Files Two Patent Applications for Innovative Cannabis Extraction Processes
PR
Neptune Technologies & Bioressources : to Hold Conference Call to Discuss First Quarter Results Ended June 30th, 2018
PU
Neptune Technologies & Bioressources : to Hold Conference Call to Discuss First Quarter Results for the Three Months Period Ended June 30, 2018
PR
Neptune Technologies & Bioressources : Announces Fourth Quarter and Year-end Results
PR
Neptune Technologies & Bioressources : Announces Fourth Quarter and Year-end Results
PU
Neptune Technologies & Bioressources : to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year-End Results Ended March 31, 2018
PU
Neptune Technologies & Bioressources : Ketogenics
PU
Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year-End Results Ended March 31, 2018
GL
Neptune Technologies & Bioressources : Announces Third Quarter Results
MW
Neptune Technologies & Bioressources : and Tetra Bio-Pharma Enter Co-Development Agreement for Purified Cannabinoid Oil-Based Products targeting Pain and Inflammation
MW
Neptune Technologies & Bioressources : and Tetra Bio-Pharma Enter Co-Development Agreement for Purified Cannabinoid Oil-Based Products targeting Pain and Inflammation
MW
Neptune Technologies & Bioressources : to Hold Conference Call to Discuss Third Quarter Results for the Interim Period Ended December 31, 2017
MW
Neptune Technologies & Bioressources : Announces Research Agreement Aimed at New Medical and Wellness Cannabinoid-based Products
MW
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. Stock
  5. News Neptune Technologies & Bioressources-Ord